233 related articles for article (PubMed ID: 10511072)
1. A review of the pharmacokinetics and pharmacodynamics of remifentanil.
Glass PSA; Gan TJ; Howell S
Anesth Analg; 1999 Oct; 89(4 Suppl):7. PubMed ID: 10511072
[No Abstract] [Full Text] [Related]
2. [Pharmacodynamics and pharmacokinetics of remifentanil: overview and comparison with other opioids].
Kato M; Satoh D; Okada Y; Sugiyama K; Toda N; Kurosawa S
Masui; 2007 Nov; 56(11):1281-6. PubMed ID: 18027596
[TBL] [Abstract][Full Text] [Related]
3. An overview of remifentanil.
Rosow CE
Anesth Analg; 1999 Oct; 89(4 Suppl):1. PubMed ID: 10511070
[No Abstract] [Full Text] [Related]
4. Educational considerations for the clinical introduction and use of remifentanil.
Reves JG
Anesth Analg; 1999 Oct; 89(4 Suppl):4. PubMed ID: 10511071
[No Abstract] [Full Text] [Related]
5. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.
Minto CF; Schnider TW; Egan TD; Youngs E; Lemmens HJ; Gambus PL; Billard V; Hoke JF; Moore KH; Hermann DJ; Muir KT; Mandema JW; Shafer SL
Anesthesiology; 1997 Jan; 86(1):10-23. PubMed ID: 9009935
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery.
Drover DR; Lemmens HJ
Anesthesiology; 1998 Oct; 89(4):869-77. PubMed ID: 9778004
[TBL] [Abstract][Full Text] [Related]
7. Remifentanil; from pharmacological properties to clinical practice.
Servin F
Adv Exp Med Biol; 2003; 523():245-60. PubMed ID: 15088856
[No Abstract] [Full Text] [Related]
8. Pharmacology of remifentanil.
Glass PS
Eur J Anaesthesiol Suppl; 1995 May; 10():73-4. PubMed ID: 7641649
[No Abstract] [Full Text] [Related]
9. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures.
Ross AK; Davis PJ; Dear Gd GL; Ginsberg B; McGowan FX; Stiller RD; Henson LG; Huffman C; Muir KT
Anesth Analg; 2001 Dec; 93(6):1393-401, table of contents. PubMed ID: 11726413
[TBL] [Abstract][Full Text] [Related]
10. Remifentanil: an esterase-metabolized opioid.
Egan TD
West J Med; 1997 Mar; 166(3):202. PubMed ID: 9143197
[No Abstract] [Full Text] [Related]
11. The use of ultra-short-acting opioids in paediatric anaesthesia: the role of remifentanil.
Davis PJ; Cladis FP
Clin Pharmacokinet; 2005; 44(8):787-96. PubMed ID: 16029065
[TBL] [Abstract][Full Text] [Related]
12. Remifentanil: a new opioid.
Glass PS
J Clin Anesth; 1995 Nov; 7(7):558-63. PubMed ID: 8652166
[TBL] [Abstract][Full Text] [Related]
13. A physiologically-based model to predict individual pharmacokinetics and pharmacodynamics of remifentanil.
Cascone S; Lamberti G; Piazza O; Abbiati RA; Manca D
Eur J Pharm Sci; 2018 Jan; 111():20-28. PubMed ID: 28939143
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics and pharmacodynamics of remifentanil in volunteers with severe hepatic or renal dysfunction.
Dershwitz M; Rosow CE
J Clin Anesth; 1996 May; 8(3 Suppl):88S-90S. PubMed ID: 8695124
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics in anesthetic drug development.
Shafer SL
Acta Anaesthesiol Belg; 1998; 49(2):65-78. PubMed ID: 9675375
[No Abstract] [Full Text] [Related]
16. Experience with remifentanil in neurosurgical patients.
Warner DS
Anesth Analg; 1999 Oct; 89(4 Suppl):33. PubMed ID: 10511076
[No Abstract] [Full Text] [Related]
17. Measured context-sensitive half-times of remifentanil and alfentanil.
Kapila A; Glass PS; Jacobs JR; Muir KT; Hermann DJ; Shiraishi M; Howell S; Smith RL
Anesthesiology; 1995 Nov; 83(5):968-75. PubMed ID: 7486182
[TBL] [Abstract][Full Text] [Related]
18. The role of newer opioids in geriatric anesthesia.
Shafer SL
Acta Anaesthesiol Belg; 1998; 49(2):91-103. PubMed ID: 9675378
[TBL] [Abstract][Full Text] [Related]
19. [Remifentanil--ultra-short acting opioid and its possible applications in anesthesiology].
Knapik M; Misiołek H; Knapik P; Dyaczyńska-Herman A
Wiad Lek; 2005; 58(5-6):353-7. PubMed ID: 16238133
[TBL] [Abstract][Full Text] [Related]
20. [Ultiva (remifentanil hydrochloride), intravenous dose of 2mg, 5mg: pharmacological and clinical profile].
Nomura S; Arai T; Takeuchi S; Masui A; Wakamatsu A; Harada Y
Nihon Yakurigaku Zasshi; 2007 Oct; 130(4):321-9. PubMed ID: 17938519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
